US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist
  • 4.650
  • +0.090+1.97%
Close Oct 31 16:00 ET
  • 4.650
  • 0.0000.00%
Post 16:02 ET
271.05MMarket Cap-24473P/E (TTM)

Vanda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vanda Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 6, 2024

Estimate YoY
Revenue
50.73M
+30.70%
EPS
-0.16
--
Analyst Rating
Buy

Oct 31, 2024

Vanda Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Nov 6, 20242024/Q3-- / 50.732M--
May 3, 20232023/Q1-- / 62.500M--
Jul 31, 20242024/Q250.474M / 47.860M--
Feb 7, 20242023/Q445.271M / 37.000M--
Nov 8, 20232023/Q338.815M / 44.500M--
DatePeriodRevenue/EstimateEarnings Call
Nov 6, 20242024/Q3-- / 50.732M--
May 3, 20232023/Q1-- / 62.500M--
Jul 31, 20242024/Q250.474M / 47.860M--
Feb 7, 20242023/Q445.271M / 37.000M--
Nov 8, 20232023/Q338.815M / 44.500M--

Unlock Free Earnings Estimates

Vanda Pharmaceuticals Earnings Reports

  • Vanda Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:07 ET

  • Vanda Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 9 07:12 ET

  • Vanda Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 8 07:25 ET

  • Vanda Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 07:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data